Clinical Trials Search at Vanderbilt-Ingram Cancer Center
Multiple Cancer Types
This study will evaluate the safety, tolerability, and efficacy of oral KPT-9274 for the treatment of patients with advanced solid malignancies or non-Hodgkin's lymphoma (NHL). Currently enrolling melanoma patients in combination with nivolumab, only.
Lymphoma, Miscellaneous, Phase I